239 related articles for article (PubMed ID: 26395593)
1. EUROmediCAT Recommendations for European Pharmacovigilance concerning safety of medication use in pregnancy.
EUROmediCAT Steering Group
Pharmacoepidemiol Drug Saf; 2015 Oct; 24 Suppl 2():3-7. PubMed ID: 26395593
[No Abstract] [Full Text] [Related]
2. EUROmediCAT: Safety of Medication Use in Pregnancy.
Pharmacoepidemiol Drug Saf; 2015 Oct; 24 Suppl 2():1-2. PubMed ID: 26395592
[No Abstract] [Full Text] [Related]
3. French pharmacovigilance: Missions, organization and perspectives.
Vial T
Therapie; 2016 Apr; 71(2):143-50. PubMed ID: 27080832
[TBL] [Abstract][Full Text] [Related]
4. Pharmacovigilance in Europe: Place of the Pharmacovigilance Risk Assessment Committee (PRAC) in organisation and decisional processes.
Laroche ML; Batz A; Géniaux H; Féchant C; Merle L; Maison P
Therapie; 2016 Apr; 71(2):161-9. PubMed ID: 27080834
[TBL] [Abstract][Full Text] [Related]
5. The reorganisation of European pharmacovigilance. Part 2. From spontaneous reports to agency reviews and decisions.
Prescrire Int; 2015 Feb; 24(157):50-4. PubMed ID: 25802924
[TBL] [Abstract][Full Text] [Related]
6. Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology.
Baldo P; Francescon S; Fornasier G
Int J Clin Pharm; 2018 Aug; 40(4):748-753. PubMed ID: 30094557
[TBL] [Abstract][Full Text] [Related]
7. [Editorial: adverse drug reactions].
Taegtmeyer AB
Ther Umsch; 2015 Dec; 72(11-12):667. PubMed ID: 26654808
[No Abstract] [Full Text] [Related]
8. [Adverse drug reaction - Definitions, risk factors and pharmacovigilance].
Krähenbühl S
Ther Umsch; 2015 Dec; 72(11-12):669-71. PubMed ID: 26654809
[TBL] [Abstract][Full Text] [Related]
9. Promoting and Protecting Public Health: How the European Union Pharmacovigilance System Works.
Santoro A; Genov G; Spooner A; Raine J; Arlett P
Drug Saf; 2017 Oct; 40(10):855-869. PubMed ID: 28735357
[TBL] [Abstract][Full Text] [Related]
10. Strengthening standards, transparency, and collaboration to support medicine evaluation: Ten years of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP).
Kurz X; Perez-Gutthann S;
Pharmacoepidemiol Drug Saf; 2018 Mar; 27(3):245-252. PubMed ID: 29327451
[No Abstract] [Full Text] [Related]
11. Obstacles to transparency over pharmacovigilance data within the EMA.
Prescrire Int; 2015 Nov; 24(165):278-9. PubMed ID: 26688911
[TBL] [Abstract][Full Text] [Related]
12. Pharmacovigilance in Europe.
Johnson CL; Hutchinson JA
Transplantation; 2015 Aug; 99(8):1542-3. PubMed ID: 26308299
[No Abstract] [Full Text] [Related]
13. Encouraging spontaneous reporting of adverse effects.
Prescrire Int; 2015 Feb; 24(157):53. PubMed ID: 25802925
[TBL] [Abstract][Full Text] [Related]
14. Pharmacovigilance and communicating safety information.
Drug Ther Bull; 2012 Dec; 50(12):138-40. PubMed ID: 23241564
[TBL] [Abstract][Full Text] [Related]
15. Measuring the impact of the 2012 European pharmacovigilance legislation on additional risk minimization measures.
Francisca RDC; Zomerdijk IM; Sturkenboom MCJM; Straus SMJM
Expert Opin Drug Saf; 2018 Oct; 17(10):975-982. PubMed ID: 30107752
[TBL] [Abstract][Full Text] [Related]
16. [Terappel: description of a computerised database and examples of studies].
Vial T; Gouraud A; Bernard N
Therapie; 2014; 69(1):31-8. PubMed ID: 24698186
[TBL] [Abstract][Full Text] [Related]
17. Fifty years of pharmacovigilance - Medicines safety and public health.
Laporte JR
Pharmacoepidemiol Drug Saf; 2016 Jun; 25(6):725-32. PubMed ID: 26799344
[No Abstract] [Full Text] [Related]
18. [Pharmacovigiance: The spontaneous reporting system in Switzerland].
Schäublin M
Ther Umsch; 2015 Dec; 72(11-12):743-8. PubMed ID: 26654819
[TBL] [Abstract][Full Text] [Related]
19. Improving the Safety of Medicines in the European Union: From Signals to Action.
Potts J; Genov G; Segec A; Raine J; Straus S; Arlett P
Clin Pharmacol Ther; 2020 Mar; 107(3):521-529. PubMed ID: 31621897
[TBL] [Abstract][Full Text] [Related]
20. Enhancing Pharmacovigilance Capabilities in the EU Regulatory Network: The SCOPE Joint Action.
Radecka A; Loughlin L; Foy M; de Ferraz Guimaraes MV; Sarinic VM; Di Giusti MD; Lesicar M; Straus S; Montero D; Pallos J; Ivanovic J; Raine J
Drug Saf; 2018 Dec; 41(12):1285-1302. PubMed ID: 30128638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
